Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus Combined With All Trans Retinoic Acid for the Treatment of Auto-Immune Anemia

NCT04324411 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT04324411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04324411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus Combined With All Trans Retinoic Acid for the Treatment of Auto-Immune Anemia
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
April 20, 2020
Completion date
September 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune anemia